Collegium to Present at Upcoming Investor Conferences
The Jefferies Global Healthcare Conference onThursday, June 7 th at9:30 a.m. ET inNew York City The William Blair Growth Stock Conference onWednesday, June 13 th at7:00 a.m. ET inChicago
About
Collegium is a specialty pharmaceutical company focused on becoming the leader in responsible pain management by developing and commercializing innovative, differentiated products for patients suffering from pain.
About Xtampza ER
Xtampza® ER is Collegium’s first product utilizing the DETERx technology platform. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone approved by the
Contact:
adasalla@collegiumpharma.com
Source: Collegium Pharmaceutical, Inc.